2021
Untwisting the complexity of midgut malrotation and volvulus ultrasound
Nguyen HN, Navarro OM, Guillerman RP, Silva CT, Sammer MBK. Untwisting the complexity of midgut malrotation and volvulus ultrasound. Pediatric Radiology 2021, 51: 658-668. PMID: 33398405, DOI: 10.1007/s00247-020-04876-x.Peer-Reviewed Original ResearchConceptsMidgut volvulusMidgut malrotationCommon conditionAcute abdominal signsUpper gastrointestinal seriesUpper GI seriesHypertrophic pyloric stenosisDiagnostic imaging testsOral contrast agentAbdominal signsAbdominal USGastrointestinal seriesGI seriesPrompt treatmentClinical presentationPyloric stenosisDiagnostic findingsImaging testsPictorial essayUS protocolVolvulusMalrotationContrast agentsEnterocolitisAppendicitis
2019
So I am Getting a CT for Small Bowel Obstruction, Do I Need Oral Contrast? IV Contrast?
Gettel C, Cummings C. So I am Getting a CT for Small Bowel Obstruction, Do I Need Oral Contrast? IV Contrast? 2019, 175-176. DOI: 10.1007/978-3-319-98343-1_49.Peer-Reviewed Original Research
2017
Contrast Agents for MR Imaging
Czeyda-Pommersheim F, Martin DR, Costello JR, Kalb B. Contrast Agents for MR Imaging. Magnetic Resonance Imaging Clinics Of North America 2017, 25: 705-711. PMID: 28964460, DOI: 10.1016/j.mric.2017.06.011.ChaptersConceptsAdverse eventsContrast mediumMR imagingCommon adverse eventsOral MR contrast agentGadolinium-based contrastContrast agentsOral contrast agentSpecific clinical questionsExcellent safety recordCT contrast mediaIron-based agentVariety of agentsLower incidenceClinical questionsSpecific contrast agentsClinical useMR contrast agentsSafety recordAgentsImagingIncidencePharmacology
1999
A multisite phase III study of the safety and efficacy of a new manganese chloride‐based gastrointestinal contrast agent for MRI of the abdomen and pelvis
Small W, DeSimone‐Macchi D, Parker J, Sukerkar A, Hahn P, Rubin D, Zelch J, Kuhlman J, Outwater E, Weinreb J, Brown J, de Lange E, Woodward P, Arildsen R, Foster G, Runge V, Aisen A, Muroff L, Thoeni R, Parisky Y, Tanenbaum L, Totterman S, Herfkens R, Knudsen J, Laster R, Duerinckx A, Stillman A, Spritzer C, Saini S, Rofsky N, Bernardino M. A multisite phase III study of the safety and efficacy of a new manganese chloride‐based gastrointestinal contrast agent for MRI of the abdomen and pelvis. Journal Of Magnetic Resonance Imaging 1999, 10: 15-24. PMID: 10398973, DOI: 10.1002/(sici)1522-2586(199907)10:1<15::aid-jmri3>3.0.co;2-x.Peer-Reviewed Original ResearchConceptsGastrointestinal contrast agentAdverse eventsSite investigatorsGastrointestinal tract side effectsPatient diagnosisBlinded readersMore adverse eventsPhase III studyInflammatory bowel diseaseGroup of patientsPeptic ulcer diseaseML of placeboT2-weighted MRI scansMultisite clinical trialContrast agentsOral contrast agentAdditional diagnostic informationPlacebo patientsOral agentsIII studyBowel diseaseUlcer diseaseGastrointestinal pathologyLaboratory changesPhysical examination
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply